SCHEMBL17034867

SCHEMBL17034867

COc1ccc(-c2nc3ccccc3c3c2ccc2ccccc23)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.60
KDM4E B2RXH2 5/20 0.60
ALDH1A1 P00352 5/20 0.60
L3MBTL1 Q9Y468 2/20 0.60
NPSR1 Q6W5P4 2/20 0.60
TDP1 Q9NUW8 1/20 0.60
ADORA2A P29274 1/20 0.59
MAPT P10636 4/20 0.51
MAPK1 P28482 1/20 0.51
NPC1 O15118 4/20 0.50
RAB9A P51151 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50
RELA Q04206 2/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
HPGD P15428 2/20 0.49
ACACA Q13085 1/20 0.49
HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18347009 0.87 KDM4E (0.50) LMNAKDM4EALDH1A1L3MBTL1NPSR1
SCHEMBL17034859 0.85 ADORA2A (0.62) LMNAKDM4EALDH1A1L3MBTL1NPSR1
SCHEMBL18200601 0.85 NUDT1 (0.47) LMNAKDM4EALDH1A1L3MBTL1NPSR1
SCHEMBL18200600 0.85 NUDT1 (0.47) LMNAKDM4EALDH1A1L3MBTL1NPSR1
SCHEMBL17034863 0.85 NUDT1 (0.50) LMNAKDM4EALDH1A1L3MBTL1NPSR1
SCHEMBL17034868 0.84 TDP1 (0.57) LMNAKDM4EALDH1A1L3MBTL1NPSR1
SCHEMBL18201033 0.82 ESR1 (0.42) KDM4EALDH1A1ADORA2AMEN1KMT2A
SCHEMBL18200538 0.82 ESR1 (0.42) KDM4EALDH1A1ADORA2AMEN1KMT2A
SCHEMBL18200604 0.82 ESR1 (0.42) KDM4EALDH1A1ADORA2AMEN1KMT2A
SCHEMBL18200645 0.82 MAPK8 (0.43) LMNAKDM4EALDH1A1ADORA2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 LMNA 1598/4885KDM4E 3143/4885ALDH1A1 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.